Exagen

United States
Lake of the Woods, Arizona, United States, 92081

Company profile

Exagen company profile

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen’s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. Exagen was established in 2002 and is headquartered in Vista, California.

Business identity

Contact email
[email protected]
Phone number
888-452-1522
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$50,000+
Founded
2002-01-01, Year

Headquarters

Postal code
92081
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
26
Total equity funding
$248.7M
Last funding
Post IPO Equity / $20.2M / 2025-05-08
Last equity funding
Post IPO Equity / $20.2M
Investors
11
Lead investors
5
Founders
3
Articles
160
Exited on
2019-09-18

Founders and investors

Founders

Cole HarrisGiorgio CasaburiWaneta Tuttle

Lead investors

Cottonwood Technology FundH.I.G. BioHealth PartnersInnovatus Capital PartnersPerceptive AdvisorsTullis Health Investors

Investors

Cottonwood Technology FundCRGEPIC VenturesPerceptive AdvisorsSun Mountain Capital